Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical Reviews in Allergy & Immunology
Metadata
Title
Intravenous immunoglobulin and fibrosis
Authors
Vered Molina
Miri Blank
Yehuda Shoenfeld
Publication date
01-12-2005
Publisher
Humana Press
Published in
Clinical Reviews in Allergy & Immunology / Issue 3/2005
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1385/CRIAI:29:3:321

Other articles of this Issue 3/2005

Clinical Reviews in Allergy & Immunology 3/2005 Go to the issue

OriginalPaper

Intravenous immunoglobulin therapy and systemic lupus erythematosus

OriginalPaper

Intravenous immunoglobulin in immunodeficiency states

Erratum

Making the diagnosis of asthma in the athlete

OriginalPaper

Intravenous immunoglobulin

OriginalPaper

Intravenous immunoglobulin and multiple sclerosis

OriginalPaper

Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits